CAM
BNTX icon

Chesapeake Asset Management’s BioNTech BNTX Stock Holding History

Chesapeake Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25
Closed -$2.64K – 341
2023
Q4 		$2.64K Hold
25
– – ﹤0.01% 339
2023
Q3 		$2.72K Buy
+25
New +$2.77K ﹤0.01% 358

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Chesapeake Asset Management's BNTX Position: Q1 2024 in Review

Chesapeake Asset Management sold out of BioNTech (BNTX) in Q1 2024, closing a stake of 25 shares — an estimated $2.64K sold.

Chesapeake Asset Management first reported a position in BNTX in Q3 2023 and held it in 2 quarters. The position peaked at $2.72K in Q3 2023. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

  • Chesapeake Asset Management reported no remaining BioNTech position as of Q1 2024 after selling out during the quarter.
  • Chesapeake Asset Management sold 25 BioNTech shares in Q1 2024, an estimated $2.64K.
  • Chesapeake Asset Management first reported a position in BioNTech in Q3 2023 and held it in 2 quarters.
  • Chesapeake Asset Management's BioNTech position peaked at $2.72K in Q3 2023.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on Chesapeake Asset Management's 13F filing for Q1 2024, filed 5 Jan 2026.